Thursday, June 14, 2018 3:32:11 PM
Response/clearance for general use 6-10 weeks
Filing for post surgical use?
Dr Scholls/possible other deals post-muskuloskeletal clearance?
FDA Innovation Challenge-November 2018
Update on path forward for allay?
Good stuff above. I guess i should have put quarterly earnings in there too. I didn't expect a lot from B Braun for this Q and after Uncle Andy saying how slow it was going there won't be an upside surprise from them. Maybe we will see an uptick in sales from the build up of inventory for the UK.
We may also get some details on the Sweden situation. Having a second country's health service start using Actipatch will be further confirmation that it can reduce healthcare costs. BIEL has part of the solution for two major political hot button issues, healthcare costs and opioid addiction. That's why if we get chosen in the FDA Innovation Challenge, it will be a big deal.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
